Market Place
Sourcing Support
Avenacy to Share Company’s Year One Progress at CPHI Milan 2024
23 Sep 2024 //
BUSINESSWIRE
Avenacy Launches Metoclopramide Injection In U.S. Market
16 Sep 2024 //
BUSINESSWIRE
Avenacy Announces Dr. Patrick Soon-Shiong As Major Investor And Co-Founder
20 Aug 2024 //
BUSINESSWIRE
Avenacy Launches Palonosetron Hydrochloride Injection In US Market
22 Jul 2024 //
BUSINESSWIRE
Avenacy Announces Launch Of Prochlorperazine Edisylate in the U.S. Market
26 Jun 2024 //
BUSINESSWIRE
Avenacy launches Tranexamic Acid Injection, USP in the U.S. market.
24 Jun 2024 //
BUSINESSWIRE
Avenacy Launches Isoproterenol Hydrochloride Injection In US
20 May 2024 //
BUSINESSWIRE
Avenacy Announces US Launch Of Magnesium Sulfate Injection
14 May 2024 //
BUSINESSWIRE
Avenacy Announces Launch of Eptifibatide for Injection in the U.S. Market
29 Apr 2024 //
BUSINESSWIRE
Avenacy Launches Desmopressin Acetate Injection In US
15 Apr 2024 //
BUSINESSWIRE
Avenacy Announces Launch of Furosemide for Injection in the U.S. Market
20 Mar 2024 //
BUSINESSWIRE
Avenacy Announces New Product Launches and Participation in DCAT Week 2024
18 Mar 2024 //
BUSINESSWIRE
Avenacy Announces Launch of Bivalirudin for Injection in the U.S. Market
29 Jan 2024 //
BUSINESSWIRE
Avenacy Announces Launch of Melphalan Hydrochloride for Injection
16 Jan 2024 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.